The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.
  • Ticker

RNS




GlaxoSmithKline PLC - GSK Half Yearly Report
12:00 23-Jul-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK MEK/BRAF combination phase III study update
14:00 17-Jul-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Start of phase III study - FF/UMEC/VI combination
07:00 16-Jul-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Breo Ellipta US regulatory submission
13:00 30-Jun-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Triumeq receives positive CHMP opinion
12:42 27-Jun-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Incruse Ellipta positive data studies
12:30 11-Jun-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Serious Fraud Office Investigation
07:00 28-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Director Declaration
13:18 16-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK darapladib Phase III SOLID Study Results
07:00 13-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK GSK receives EU Marketing Authorisation for Anoro
16:00 08-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Board Committee change
12:58 08-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK Result of AGM
17:19 07-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK GSK receives US approval for Incruse Ellipta
07:00 01-May-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK 1st Quarter Results
12:00 30-Apr-2014  RNS  1.67% View chart
GlaxoSmithKline PLC - GSK GSK Receives EU Marketing Authorisation - Incruse
16:11 28-Apr-2014  RNS  1.67% View chart


RNS - regulatory news service - home


Market News Upgrade

Welcome to the latest upgrade of our Market News section, the definitive place for UK regulatory disclosures.

You will now see:

Enhanced search, filter and sort features giving you the ability to:

  • Include/exclude NAVs & FRNs
  • Exclude all announcements except earnings and news (set as default option)
  • Sort by "Most Read" announcements
  • Search announcements by FTSE index

Additional content such as:

  • Dynamic "Most Read" announcement ticker
  • Greater prominence for company logos
  • Share price change indicator


About RNS

RNS is the London Stock Exchange's regulatory and financial communications channel for companies to communicate with the professional investor.



News Sources

For information about RNS reach and News Announcements, the news sources available within the Market news section.



rssRNS feeds
Allows you to be kept updated with RNS announcements.






The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds